Funding for this research was provided by:
Foundation for the National Institutes of Health (P01 NS097206)
Received: 9 April 2021
Accepted: 22 September 2021
First Online: 10 January 2022
: The University of Chicago has filed a patent application on KAS-seq. C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc. and AccuraDX, Inc., as well as a shareholder of Epican Genetech. T.W. and D.C.W.-S. are shareholders of AccuraDX, Inc.